Use of Medications for Opioid Use Disorder and Child Welfare Outcomes

Alexandra Muhar; Elizabeth McNeer; Lauren D Presley; Anna Morad; Sarah F Loch; William D Dupont; Stephen W Patrick

doi:10.1001/jamahealthforum.2024.1768

Use of Medications for Opioid Use Disorder and Child Welfare Outcomes

JAMA Health Forum. 2024 Jul 5;5(7):e241768. doi: 10.1001/jamahealthforum.2024.1768.

Authors

Alexandra Muhar^{1

2}, Elizabeth McNeer^{2

3}, Lauren D Presley¹, Anna Morad¹, Sarah F Loch^{1

2}, William D Dupont^{2

3}, Stephen W Patrick^{1

2

4

5}

Affiliations

¹ Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
² Vanderbilt Center for Child Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee.
³ Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
⁴ Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee.
⁵ Now with Department of Health Policy and Management, Rollins School of Public Health, Atlanta, Georgia.

No abstract available

Plain language summary

This cohort study investigates whether use of medications for opioid use disorder in pregnancy is associated with higher rates of infants discharge home with their mothers after birth.

MeSH terms

Analgesics, Opioid / adverse effects
Analgesics, Opioid / therapeutic use
Buprenorphine / therapeutic use
Child
Child Welfare*
Humans
Opiate Substitution Treatment / methods
Opioid-Related Disorders* / drug therapy

Substances

Analgesics, Opioid
Buprenorphine